Page last updated: 2024-08-24

gemcitabine and chromium

gemcitabine has been researched along with chromium in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Clements, D; Giacomantonio, CA; Gujar, SA; Hill, R; Lee, PW; Madureira, PA; Rabb, M; Waisman, DM	1

Other Studies

1 other study(ies) available for gemcitabine and chromium

Article	Year
Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy. Cell death & disease, 2013, Sep-05, Volume: 4 Topics: 14-3-3 Proteins; Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Cell Line, Tumor; Chromium; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Deoxycytidine; DNA Damage; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, SCID; Models, Biological; Pancreatic Neoplasms; Protein Biosynthesis; Proto-Oncogene Proteins; Remission Induction; Transcription, Genetic; Tumor Suppressor Protein p53	2013

Article

Year

Gemcitabine-mediated tumour regression and p53-dependent gene expression: implications for colon and pancreatic cancer therapy.

Cell death & disease, 2013, Sep-05, Volume: 4

Topics: 14-3-3 Proteins; Animals; Apoptosis; Apoptosis Regulatory Proteins; bcl-2-Associated X Protein; Cell Line, Tumor; Chromium; Colonic Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Deoxycytidine; DNA Damage; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, SCID; Models, Biological; Pancreatic Neoplasms; Protein Biosynthesis; Proto-Oncogene Proteins; Remission Induction; Transcription, Genetic; Tumor Suppressor Protein p53

2013